Recommendation ID
IPG679/1
Question

NICE encourages further research into implanted vagus nerve stimulation for treatment-resistant depression, in the form of randomised controlled trials with a placebo or sham stimulation arm. Studies should report details of patient selection. Outcomes should include validated depression rating scales, patient-reported quality of life, time to onset of effect and duration of effect, and any changes in concurrent treatments.

Any explanatory notes
(if applicable)

Source guidance details

Comes from guidance
Implanted vagus nerve stimulation for treatment-resistant depression
Number
IPG679
Date issued
August 2020

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 01/08/2020